Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (348)	1/8/2001 12:59:08 PM
From: tuck	Read Replies (2) \| Respond to of 1784

PB, Thank you, sir, for that dig. >>May not happen again, as I am hearing their libraries tend to be kind of mediocre?<< I haven't heard any of our resident chemists talk favorably about anyone's libraries, execept those of SIAL. Not that there's been that much discussion. But TRPS never mentioned, and PCOP's libraries dissed. Luckily for PCOP, they have popular protein-folding software. Many stocks have suffered post-split in the last 3 quarters. But few have raised -- rather than lowered -- earnings/revenue forecasts. Last one to do that, that I can recall, was CRL, which has held up fairly well since then, despite lock-up expiration. That latter is another theme I pay attention to. I see that some companies that seemed to have weathered their lock-ups expirations are suddenly losing it. ITMN comes to mind. One that is definitely suffering from lock-up expiration is GNSL. Trickle Threadsters should be aware that PKI can pick this one up cheap if it stays down here for too long (30 day MA thing, read the S-1 yourselves). The takeout price could be in the high fives or lower. Trickle could be hurt a bit if this comes to pass, as its cost is well above that. But this may be worth a look at these levels for those of us in the real world who haven't pulled the trigger on it. Cheers, Tuck